14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of THRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

THRX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 30, 2015 Sep 08, 2015 Sep 30, 2015 $0.250 0%
2 May 07, 2015 Jun 10, 2015 Jun 30, 2015 $0.250 0%
3 Feb 24, 2015 Mar 10, 2015 Mar 31, 2015 $0.250 0%
4 Oct 31, 2014 Nov 21, 2014 Dec 23, 2014 $0.250 0%
5 Aug 07, 2014 Aug 26, 2014 Sep 18, 2014 $0.250 0%

FAQ

What is the symbol for Theseus Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Theseus Pharmaceuticals, Inc. is THRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Theseus Pharmaceuticals, Inc. Stock?
Theseus Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Theseus Pharmaceuticals, Inc. Stock?
Theseus Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Theseus Pharmaceuticals, Inc. Stock.

What's the current price of Theseus Pharmaceuticals, Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Theseus Pharmaceuticals, Inc. (THRX) share was $4.06.

What is the 52-week high and low for Theseus Pharmaceuticals, Inc. Stock?
The 52-week high for Theseus Pharmaceuticals, Inc. Stock is $12.02 and the 52-week low is $2.05.

What is the market capitalization of Theseus Pharmaceuticals, Inc. Stock?
As of the May 03, 2024, the market capitalization of Theseus Pharmaceuticals, Inc. is 181.499M.

When is the next earnings date for Theseus Pharmaceuticals, Inc.?
The upcoming earnings date for Theseus Pharmaceuticals, Inc. is May 11, 2024.
Click to get the best stock tips daily for free!

About Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals. Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes re... THRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT